https://tickeron.com/stock/VRDN/alerts/
Viridian Therapeutics (VRDN) Trading with AI Buy/Sell Alert System - Tickeron.com
Viridian Therapeutics (VRDN) Unlock your trading potential with Tickeron's AI Buy/Sell Alert System. Set target prices, receive precise buy/sell signals,...
viridian therapeuticswith ai
https://www.clinicaltrialsarena.com/news/viridian-trials-thyroid-eye-disease/
Viridian Therapeutics to begin trials of thyroid eye disease drug
Jun 12, 2024 - Viridian Therapeutics has announced plans to begin two Phase III trials of VRDN-003 to treat thyroid eye disease (TED).
thyroid eye diseaseviridian therapeuticsbegintrialsdrug
https://www.viridiantherapeutics.com/newsroom/archive/
Archive - Viridian Therapeutics, Inc.
viridian therapeuticsarchiveinc
https://lifesciencetracker.com/entries/viridian-therapeutics-08-06-2025/
Viridian Therapeutics - 08-06-2025 - Incubate Investment Tracker
Sep 26, 2025 - In May 2025, President Trump issued another Executive Order that directed government agencies and officials to identify most-favored-nation pricing targets for...
viridian therapeuticsincubateinvestmenttracker
https://markets.businessinsider.com/news/stocks/viridian-therapeutics-downgraded-to-equal-weight-from-overweight-at-wells-fargo-1034155930
Viridian Therapeutics downgraded to Equal Weight from Overweight at Wells Fargo | Markets Insider
Wells Fargo downgraded Viridian Therapeutics (VRDN) to Equal Weight from Overweight with a price target of $27, down from $37. The firm says its...